Rare diseases
Investigational molecules
Locations
Back to France3 clinical trials in Annonay, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceFranceFranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Primary IgA Nephropathy, investigating new therapeutic approaches using antisense inhibitors to address disease progression in high-risk patients.
Studies aim to evaluate treatment effectiveness through protein-to-creatinine ratio measurements.
Groundbreaking trials examining combination therapy for patients with chronic kidney disease and hypertension, focusing on innovative treatment combinations.
Research centers on measuring glomerular filtration rate changes to assess disease progression.
Advanced research investigating atherosclerotic cardiovascular disease in end-stage kidney disease patients undergoing dialysis, with focus on inflammatory markers.
Studies evaluate the impact of targeted therapies on C-reactive protein levels in dialysis patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
